The Drug Regulatory Authority of Pakistan (DRAP) has made 2D Data Matrix barcodes and serialisation compulsory for all locally manufactured and imported medicines from October 9, 2026, in a move aimed at improving drug safety and preventing the sale of fake medicines, 24NewsHD TV reported on Tuesday.
According to an official announcement, all local pharmaceutical companies and medicine importers must follow the new rules. Under the new system, medicine packaging must clearly carry the manufacturing and expiry dates, batch number, price, and a unique serial number.
DRAP has also directed companies to ensure that all information entered into its Track and Trace System exactly matches the details printed on the medicine packaging. The authority warned that incorrect information, false digital records or any changes to the submitted data would be treated as a violation of the rules.
DRAP inspectors will visit pharmaceutical factories, importers and supply chain centres to check compliance. They will also verify medicine batches and compare packaging details with the data available in the tracking system. Companies found violating the barcoding and serialisation rules will face legal action under the DRAP Act and the Drugs Act.
However, medicines manufactured before October 9, 2026, have been exempted from the new requirement. Pharmaceutical companies and distributors can continue selling their existing stocks until they are completely sold.
